is saxenda a glp 1 agonist ๐ Drug Focus: Saxenda (Liraglutide) As pharmacological management of obesity becomes Prescription Weight Loss Medications: How
Description
The WHO estimates that more than 1 billion people worldwide are living with obesity, a condition that significantly increases the risk of cardiovascular disease, type 2 diabetes, cancer, and premature mortality

Meanwhile these agents have the potential to reduce major adverse cardiovascular events (MACE) in patient with T2DM as a drug class, individual drugs have different potency and effects they need tailored approach to align with patient treatment goals rather than generalized use (117)

Hormone and Metabolic Modulators There were a few examples of S4

GB, gallbladder

Avoid vigorous agitation, repeated freeze-thaw exposure, and unnecessary environmental exposure during handling